Found: 68
Select item for more details and to access through your institution.
Comprehensive characterization of circulating tumor cells and cell‐free DNA in patients with metastatic melanoma.
- Published in:
- Molecular Oncology, 2024, v. 18, n. 11, p. 2770, doi. 10.1002/1878-0261.13650
- By:
- Publication type:
- Article
Comment on Cho et al.: Usefulness of FDG PET/CT in determining benign from malignant endobronchial obstruction.
- Published in:
- 2011
- By:
- Publication type:
- Letter
The BRAF P.V600E Mutation Status of Melanoma Lung Metastases Cannot Be Discriminated on Computed Tomography by LIDC Criteria nor Radiomics Using Machine Learning.
- Published in:
- Journal of Personalized Medicine, 2021, v. 11, n. 4, p. 257, doi. 10.3390/jpm11040257
- By:
- Publication type:
- Article
Biomarker-Oriented Therapy in Bladder and Renal Cancer.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 6, p. 2832, doi. 10.3390/ijms22062832
- By:
- Publication type:
- Article
Detection of Drug-induced Interstitial Lung Disease Caused by Cancer Treatment Using Electronic Nose Exhaled Breath Analysis.
- Published in:
- Annals of the American Thoracic Society, 2024, v. 21, n. 6, p. 989, doi. 10.1513/AnnalsATS.202401-112RL
- By:
- Publication type:
- Article
Progression of a caval vein thrombus in two patients with primary renal cell carcinoma on pretreatment with sunitinib.
- Published in:
- 2010
- By:
- Publication type:
- Letter
ASO Visual Abstract: Is a History of Optimal Staging by SLNB in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Is a History of Optimal Staging by Sentinel Lymph Node Biopsy in the Era Prior to Adjuvant Therapy Associated with Improved Outcome Once Melanoma Patients have Progressed to Advanced Disease?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 573, doi. 10.1245/s10434-022-12600-2
- By:
- Publication type:
- Article
Improved postprocessing of dynamic glucose-enhanced CEST MRI for imaging brain metastases at 3 T.
- Published in:
- European Radiology Experimental, 2023, v. 7, n. 1, p. 1, doi. 10.1186/s41747-023-00390-5
- By:
- Publication type:
- Article
Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-45714-0
- By:
- Publication type:
- Article
Pemetrexed Induced Thymidylate Synthase Inhibition in Non-Small Cell Lung Cancer Patients: A Pilot Study with 3′-Deoxy-3′-[<sup>18</sup>F]fluorothymidine Positron Emission Tomography
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0063705
- By:
- Publication type:
- Article
Evaluation of the tolerability and safety of [<sup>225</sup>Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-024-11900-y
- By:
- Publication type:
- Article
A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 3, p. 759, doi. 10.1007/s00262-022-03250-0
- By:
- Publication type:
- Article
Clinical outcome of patients with metastatic melanoma of unknown primary in the era of novel therapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2021, v. 70, n. 11, p. 3123, doi. 10.1007/s00262-021-02871-1
- By:
- Publication type:
- Article
Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
- Published in:
- Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-61150-y
- By:
- Publication type:
- Article
Adverse Events in Anti-PD-1-Treated Adjuvant and First-Line Advanced Melanoma Patients.
- Published in:
- Cancers, 2024, v. 16, n. 15, p. 2656, doi. 10.3390/cancers16152656
- By:
- Publication type:
- Article
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors.
- Published in:
- Cancers, 2023, v. 15, n. 11, p. 2922, doi. 10.3390/cancers15112922
- By:
- Publication type:
- Article
Impact of Novel Treatments in Patients with Melanoma Brain Metastasis: Real-World Data.
- Published in:
- Cancers, 2023, v. 15, n. 5, p. 1461, doi. 10.3390/cancers15051461
- By:
- Publication type:
- Article
Adjuvant BRAF-MEK Inhibitors versus Anti PD-1 Therapy in Stage III Melanoma: A Propensity-Matched Outcome Analysis.
- Published in:
- Cancers, 2023, v. 15, n. 2, p. 409, doi. 10.3390/cancers15020409
- By:
- Publication type:
- Article
Using a Clinicopathologic and Gene Expression (CP-GEP) Model to Identify Stage I–II Melanoma Patients at Risk of Disease Relapse.
- Published in:
- Cancers, 2022, v. 14, n. 12, p. 2854, doi. 10.3390/cancers14122854
- By:
- Publication type:
- Article
Hospital Variation in Cancer Treatments and Survival OutComes of Advanced Melanoma Patients: Nationwide Quality Assurance in The Netherlands.
- Published in:
- Cancers, 2021, v. 13, n. 20, p. 5077, doi. 10.3390/cancers13205077
- By:
- Publication type:
- Article
Sex-Based Differences in Treatment with Immune Checkpoint Inhibition and Targeted Therapy for Advanced Melanoma: A Nationwide Cohort Study.
- Published in:
- Cancers, 2021, v. 13, n. 18, p. 4639, doi. 10.3390/cancers13184639
- By:
- Publication type:
- Article
Toxicity, Response and Survival in Older Patients with Metastatic Melanoma Treated with Checkpoint Inhibitors †.
- Published in:
- Cancers, 2021, v. 13, n. 11, p. 2826, doi. 10.3390/cancers13112826
- By:
- Publication type:
- Article
Germline Variation in PDCD1 Is Associated with Overall Survival in Patients with Metastatic Melanoma Treated with Anti-PD-1 Monotherapy.
- Published in:
- Cancers, 2021, v. 13, n. 6, p. 1370, doi. 10.3390/cancers13061370
- By:
- Publication type:
- Article
Surgery for Unresectable Stage IIIC and IV Melanoma in the Era of New Systemic Therapy.
- Published in:
- Cancers, 2020, v. 12, n. 5, p. 1176, doi. 10.3390/cancers12051176
- By:
- Publication type:
- Article
Healthcare Costs of Metastatic Cutaneous Melanoma in the Era of Immunotherapeutic and Targeted Drugs.
- Published in:
- Cancers, 2020, v. 12, n. 4, p. 1003, doi. 10.3390/cancers12041003
- By:
- Publication type:
- Article
Genome-wide aneuploidy detected by mFast-SeqS in circulating cell-free DNA is associated with poor response to pembrolizumab in patients with advanced urothelial cancer.
- Published in:
- Molecular Oncology, 2022, v. 16, n. 10, p. 2086, doi. 10.1002/1878-0261.13196
- By:
- Publication type:
- Article
Oncological healthcare providers' perspectives on appropriate melanoma survivorship care: a qualitative focus group study.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-10759-9
- By:
- Publication type:
- Article
Assessment of imaging biomarkers in the follow-up of brain metastases after SRS.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 11, p. 1983, doi. 10.1093/neuonc/noab160
- By:
- Publication type:
- Article
Adjuvant treatment with anti‐PD‐1 in acral melanoma: A nationwide study.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 8, p. 1455, doi. 10.1002/ijc.35060
- By:
- Publication type:
- Article
The development of brain metastases in patients with different therapeutic strategies for metastatic renal cell cancer.
- Published in:
- International Journal of Cancer, 2024, v. 155, n. 6, p. 1045, doi. 10.1002/ijc.34984
- By:
- Publication type:
- Article
A prediction model for response to immune checkpoint inhibition in advanced melanoma.
- Published in:
- International Journal of Cancer, 2024, v. 154, n. 10, p. 1760, doi. 10.1002/ijc.34853
- By:
- Publication type:
- Article
Adjuvant treatment of in‐transit melanoma: Narrowing the knowledge gap left by clinical trials.
- Published in:
- International Journal of Cancer, 2023, v. 153, n. 2, p. 389, doi. 10.1002/ijc.34485
- By:
- Publication type:
- Article
Time interval from primary melanoma to first distant recurrence in relation to patient outcomes in advanced melanoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 12, p. 2493, doi. 10.1002/ijc.34479
- By:
- Publication type:
- Article
The unfavorable effects of COVID‐19 on Dutch advanced melanoma care.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 5, p. 816, doi. 10.1002/ijc.33833
- By:
- Publication type:
- Article
Discontinuation of anti‐PD‐1 monotherapy in advanced melanoma—Outcomes of daily clinical practice.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 2, p. 317, doi. 10.1002/ijc.33800
- By:
- Publication type:
- Article
Silicone Breast Implants and Anaplastic Large T-Cell Lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Letter
Biodistribution and radiation dosimetry of C-labelled docetaxel in cancer patients.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2010, v. 37, n. 10, p. 1950, doi. 10.1007/s00259-010-1489-y
- By:
- Publication type:
- Article
Microvessel density and p53 in detecting cervical cancer by FDG PET in cases of suspected recurrence.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2006, v. 33, n. 12, p. 1408, doi. 10.1007/s00259-006-0108-4
- By:
- Publication type:
- Article
Association between single-nucleotide polymorphisms and adverse events in nivolumab-treated non-small cell lung cancer patients.
- Published in:
- 2018
- By:
- Publication type:
- journal article
<sup>68</sup>Ga-PSMA PET/CT for Response Evaluation of <sup>223</sup>Ra Treatment in Metastatic Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 10, p. 1556, doi. 10.2967/jnumed.123.265489
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 12, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 11, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 10, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 9, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 8, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 7, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 6, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
68Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 5, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article
<sup>68</sup>Ga-PSMA guided bone biopsies for molecular diagnostics in metastatic prostate cancer patients.
- Published in:
- Journal of Nuclear Medicine, 2020, v. 61, n. 4, p. 1, doi. 10.2967/jnumed.119.241109
- By:
- Publication type:
- Article